The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II study on the feasibility and efficacy of neoadjuvant chemotherapy for locally advanced rectal cancer.
 
Saori Goto
No Relationships to Disclose
 
Suguru Hasegawa
No Relationships to Disclose
 
Takuya Matsumoto
No Relationships to Disclose
 
Koya Hida
No Relationships to Disclose
 
Junichiro Kawamura
No Relationships to Disclose
 
Satoshi Yamanokuchi
No Relationships to Disclose
 
Takashi Yamaguchi
No Relationships to Disclose
 
Ryo Matsusue
No Relationships to Disclose
 
Yoshio Kadokawa
No Relationships to Disclose
 
Shigeru Kato
No Relationships to Disclose
 
Dai Manaka
No Relationships to Disclose
 
Ryuta Nishitai
No Relationships to Disclose
 
Akinari Nomura
No Relationships to Disclose
 
Akiyoshi Kanazawa
No Relationships to Disclose
 
Kenji Kawada
No Relationships to Disclose
 
Takahisa Kyogoku
No Relationships to Disclose
 
Yoshiharu Sakai
Honoraria - Chugai Pharma; Covidien; Johnson & Johnson; Olympus; Stryker; Taiho Pharmaceutical; Takeda; Terumo; Yakult Pharmaceutical
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Otsuka (Inst); Sanofi (Inst); Shionogi (Inst); Taiho Pharmaceutical (Inst); Tsumura & Co. (Inst); Yakult Pharmaceutical (Inst)